Application of a challenge model to assess the protective efficacy of oral typhoid vaccines in humans

Application of a challenge model to assess the protective efficacy of oral typhoid vaccines in humans

<p>Human infection by Salmonella Typhi has been occurring for the last 50,000 years and still accounts for &Tilde; 22million new cases each year worldwide. Through faeco-oral transmission, this human-restricted infection disproportionately affects the most impoverished sections of ende...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Darton, T, Pollard, A, Angus, B
Formaat:	Thesis
Taal:	English
Gepubliceerd in:	2014
Onderwerpen:	Vaccines

Gelijkaardige items

Typhoid epidemiology, diagnostics and the human challenge model.
door: Darton, T, et al.
Gepubliceerd in: (2014)

Induction of Cell Cycle and NK Cell Responses by Live-Attenuated Oral Vaccines against Typhoid Fever
door: Christoph J. Blohmke, et al.
Gepubliceerd in: (2017-10-01)

Advancing the management and control of typhoid fever: A review of the historical role of human challenge studies
door: Waddington, C, et al.
Gepubliceerd in: (2014)

Molecular correlates of vaccine-induced protection against typhoid fever
door: Henderson Zhu, et al.
Gepubliceerd in: (2023-08-01)

Advancing the management and control of typhoid fever: a review of the historical role of human challenge studies.
door: Waddington, C, et al.
Gepubliceerd in: (2014)

Typhoid vaccines. Historical aspects of typhoid vaccine development, and currently available products
door: M. V. Abramtseva, et al.
Gepubliceerd in: (2021-07-01)

Why the development of effective typhoid control measures requires the use of human challenge studies.
door: Jones, C, et al.
Gepubliceerd in: (2014)

A <i>Salmonella</i> Typhi Controlled Human Infection Study for Assessing Correlation between Bactericidal Antibodies and Protection against Infection Induced by Typhoid Vaccination
door: Elizabeth Jones, et al.
Gepubliceerd in: (2021-06-01)

Assessment of vaccine herd protection in a cluster-randomised trial of Vi conjugate vaccine against typhoid fever: results of further analysisResearch in context
door: Farhana Khanam, et al.
Gepubliceerd in: (2023-04-01)

Why the development of effective typhoid control measures requires the use of human challenge studies
door: Claire eJones, et al.
Gepubliceerd in: (2014-12-01)

Opinion of Parents Regarding Conjugate Typhoid Vaccine
door: M.Hanif Memon, et al.
Gepubliceerd in: (2020-12-01)

Importance of Salmonella Typhi-Responsive CD8+ T Cell Immunity in a Human Typhoid Fever Challenge Model
door: Fresnay, S, et al.
Gepubliceerd in: (2017)

A forecast of typhoid conjugate vaccine introduction and demand in typhoid endemic low- and middle-income countries to support vaccine introduction policy and decisions
door: Vittal Mogasale, et al.
Gepubliceerd in: (2017-09-01)

Typhoid vaccine landscape
door: Pollard, A
Gepubliceerd in: (2012)

Costs of typhoid vaccination for international travelers from the United States
door: Heesoo Joo, et al.
Gepubliceerd in: (2025-03-01)

Oral challenge with wild-type Salmonella Typhi induces distinct changes in B cell subsets in individuals who develop typhoid disease.
door: Toapanta, F, et al.
Gepubliceerd in: (2016)

Oral wild-type Salmonella Typhi challenge induces activation of circulating monocytes and dendritic cells in individuals who develop typhoid disease
door: Toapanta, F, et al.
Gepubliceerd in: (2015)

Using a human challenge model of infection to measure vaccine efficacy: a randomised, controlled trial comparing the typhoid vaccines M01ZH09 with placebo and Ty21a
door: Darton, T, et al.
Gepubliceerd in: (2016)

Oral Cholera Vaccine Efficacy and Effectiveness
door: Katerina Rok Song, et al.
Gepubliceerd in: (2021-12-01)

Salmonella Typhi-specific multifunctional CD8+ T cells play a dominant role in protection from typhoid fever in humans
door: Fresnay, S, et al.
Gepubliceerd in: (2016)

Public engagement during a typhoid conjugate vaccine trial in Lalitpur, Nepal- experience, challenges and lessons learnt
door: Ashata Dahal, et al.
Gepubliceerd in: (2022-11-01)

Typhoid vaccine: A case for inclusion in national program
door: Pragya Sharma, et al.
Gepubliceerd in: (2011-01-01)

Vi-Vaccinations Induce Heterogeneous Plasma Cell Responses That Associate With Protection From Typhoid Fever
door: Deborah L. Cross, et al.
Gepubliceerd in: (2020-12-01)

Typhoid conjugate vaccines: a step towards typhoid control
door: Shakya, M, et al.
Gepubliceerd in: (2024)

Demonstration of primary and asymptomatic DNAaemia in participants challenged with Salmonella Typhi (Quailes strain) during the development of a human model of typhoid infection
door: Darton, T, et al.
Gepubliceerd in: (2012)

Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection
door: Kawsar R. Talaat, et al.
Gepubliceerd in: (2021-04-01)

Typhoid in Pakistan: Challenges, Efforts, and Recommendations
door: Tharwani ZH, et al.
Gepubliceerd in: (2022-05-01)

Malawi vaccination drive: An integrated immunization campaign against typhoid, measles, rubella, and polio; health benefits and potential challenges
door: Adriano Focus Lubanga, et al.
Gepubliceerd in: (2023-08-01)

The Typhoid Vaccine Acceleration Consortium (TyVAC): vaccine effectiveness study designs: accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26-27 October 2016, Oxford, UK
door: Meiring, J, et al.
Gepubliceerd in: (2017)

Mucosal-Associated Invariant T cells exhibit distinct functional signatures associated with protection against typhoid fever
door: Salerno-Gonçalves, R, et al.
Gepubliceerd in: (2022)

Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting: a modeling study
door: Maile T. Phillips, et al.
Gepubliceerd in: (2023-03-01)

Induction of cell cycle and NK cell responses by live-attenuated oral vaccines against typhoid fever
door: Blohmke, CJ, et al.
Gepubliceerd in: (2017)

Investigation of the role of typhoid toxin in acute typhoid fever in a human challenge model
door: Gibani, M, et al.
Gepubliceerd in: (2019)

Why Is Eradicating Typhoid Fever So Challenging: Implications for Vaccine and Therapeutic Design
door: Yi-An Yang, et al.
Gepubliceerd in: (2018-07-01)

Typhoid conjugate vaccines: making vaccine history in Africa
door: James E. Meiring, et al.
Gepubliceerd in: (2018-08-01)

Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a.
door: Thomas C Darton, et al.
Gepubliceerd in: (2016-08-01)

A mathematical model on the transmission dynamics of typhoid fever with treatment and booster vaccination
door: Abdulai Kailan Suhuyini, et al.
Gepubliceerd in: (2023-04-01)

Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model.
door: McArthur, M, et al.
Gepubliceerd in: (2015)

Modelling the impact of vaccination on transmission dynamics of Typhoid fever
door: Fatimah O. Lawal, et al.
Gepubliceerd in: (2023-12-01)

Oral Challenge with Wild-Type Salmonella Typhi Induces Distinct Changes in B Cell Subsets in Individuals Who Develop Typhoid Disease.
door: Franklin R Toapanta, et al.
Gepubliceerd in: (2016-06-01)